-
Cariprazine, sold
under the
brand names Vraylar,
Reagila and
Symvenu among others, is an
atypical antipsychotic developed by
Gedeon Richter,
which is...
- brexpiprazole,
cariprazine, olanzapine, and
quetiapine have been
approved as
adjunct treatment for MDD by the FDA in the
United States.
Cariprazine, Quetiapine...
- Richter's
atypical antipsychotic, Reagila,
containing the
active ingredient cariprazine, was
awarded the
prize of
Medicine of the Year 2019 by the Hungarian...
-
Atypical antipsychotics (e.g., aripiprazole, asenapine, brexpiprazole,
cariprazine, clozapine, lurasidone, quetiapine, ziprasidone)
Azapirones (e.g., buspirone...
- (+sertraline)
Aripiprazole lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724...
- (+sertraline)
Aripiprazole lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724...
- receptors. The drug is also
related structurally to
brexpiprazole and
cariprazine. In
October 2023,
Reviva Pharmaceuticals released topline results from...
- an
antidepressant also used in the
treatment of
nerve pain
Vraylar (
cariprazine) –
atypical antipsychotic used to
treat schizophrenia and
bipolar mania...
-
Atypical antipsychotics (e.g., aripiprazole, asenapine, brexpiprazole,
cariprazine, clozapine, lurasidone, quetiapine, ziprasidone)
Azapirones (e.g., buspirone...
- stabilizers. Some
atypical antipsychotics (aripiprazole, asenapine,
cariprazine, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone)...
